Results 181 to 190 of about 112,374 (313)

Newly diagnosed heart failure with reduced ejection fraction: timing, sequencing, and titration of guideline-recommended medical therapy. [PDF]

Eur Heart J
Malgie J, Wilde MI, Brunner-La Rocca HP, Emans ME, De Boer GA, Siegers CEP, van Stipdonk AMW, Wardeh AJ, Schaap J, Sanders-van Wijk S, van den Heuvel M, Wierda E, De Boer RA, Koudstaal S, Brugts JJ.   +14 more
europepmc   +1 more source

Cost-Effectiveness Analysis of Sacubitril/Valsartan in Chronic Heart Failure with Reduced Ejection Fraction in Spain [PDF]

, 2016
C Lacasa, M Obradors, M. Figueras, F. Pérez-Alcántara, Max Brosa   +4 more
openalex   +1 more source

MELD score predicts outcomes in patients with advanced heart failure: A longitudinal evaluation

ESC Heart Failure, Volume 12, Issue 2, Page 839-847, April 2025.
Abstract Aims Advanced heart failure (AHF) is characterized by recurrent episodes of haemodynamic instability and frequent hospitalizations, leading to a progressive decline in quality of life and high mortality rates. The objectives of this study were to evaluate the effect of the model for end‐stage liver disease (MELD) score and its variations in ...
Francesco Curcio, Cristiano Amarelli, Rosaria Chiappetti, Irene Mattucci, Veronica Flocco, Mahmoud Issa Rammal, Ciro Abete, Francesca Mazzella, Ciro Maiello, Pasquale Abete, Francesco Cacciatore   +10 more
wiley   +1 more source

Aerobic Exercise Training, Biological Age, and Mortality in Chronic Heart Failure With Reduced Ejection Fraction. [PDF]

JACC Adv
Huang Z, Xu X, Leng Y, Ke Z, Tang Z, Fan Z, Dai R, Liao X, Zhuang X, Liang Q.   +9 more
europepmc   +1 more source

Faculty Opinions recommendation of Outcomes of patients with anemia and acute decompensated heart failure with preserved versus reduced ejection fraction (from the ARIC study community surveillance).

, 2015
Wilbert S. Aronow
openalex   +2 more sources

Transthyretin amyloid cardiomyopathy: Literature review and red‐flag symptom clusters for each cardiology specialty

ESC Heart Failure, Volume 12, Issue 2, Page 955-967, April 2025.
Abstract Wild‐type transthyretin amyloid cardiomyopathy (ATTRwt‐CM) is a progressive and infiltrative cardiac disorder that may cause fatal consequences if left untreated. The estimated survival time from diagnosis is approximately 3–6 years. Because of the non‐specificity of initial symptom manifestation and insufficient awareness among treating ...
Yasuhiro Izumiya, Toru Kubo, Jin Endo, Seiji Takashio, Masatoshi Minamisawa, Jun Hamada, Tomonori Ishii, Hajime Abe, Hiroaki Konishi, Kenichi Tsujita   +9 more
wiley   +1 more source

TCT-766 Catheter-Guided Renal Denervation Used For The Treatment Of Heart Failure With Reduced Ejection Fraction: A Meta-Analysis

, 2016
Mohammad Ansari, Daniel García, Nicolò Piazza   +2 more
openalex   +1 more source

Compliance to Bisoprolol in Patients with Heart Failure with Reduced Ejection Fraction Attending a General Cardiology Clinic [PDF]

, 2016
Jason Davis, Gerry Kaye, Matthew Rowe, Dariusz Korczyk, Goce Dimeski, M. E. Franklin   +5 more
openalex   +1 more source

Meta‐analysis of sotagliflozin, a dual sodium‐glucose‐cotransporter 1/2 inhibitor, for heart failure in type 2 diabetes

ESC Heart Failure, Volume 12, Issue 2, Page 968-979, April 2025.
Abstract Sodium‐glucose co‐transporters (SGLTs) mediate sodium and glucose transport across cell membranes. SGLT2 inhibitors have a recognized place within heart failure (HF) guidelines. We evaluated the effect of sotagliflozin on HF and cardiovascular outcomes in participants with type 2 diabetes. Scopus, Medline, Embase and Central were searched from
Maria Anna Bantounou, Panagiotis Sardellis, Josip Plascevic, Ribeya Awaes‐Mahmood, Justyna Kaczmarek, Daniel Black Boada, Rosa Thuemmler, Sam Philip   +7 more
wiley   +1 more source

On-treatment blood pressure and dose-dependent effects of ARNI in heart failure with reduced ejection fraction: Insights from a multicenter registry. [PDF]

PLoS One
Park J, Park CS, Rhee TM, Choi HJ, Choi HM, Lee HJ, Park JB, Yoon YE, Lee SP, Kim YJ, Cho GY, Kim HK, Hwang IC.   +12 more
europepmc   +1 more source